InvestorsHub Logo
Followers 0
Posts 40
Boards Moderated 0
Alias Born 09/26/2010

Re: None

Sunday, 09/26/2010 3:31:59 AM

Sunday, September 26, 2010 3:31:59 AM

Post# of 876
Millions of people love drugs (heroin, cocaine, marijuana, opium, ecstasy, lsd, hashish) and are on drugs. Everybody thinks junkies but I know such junkies who work at offshore banks, brokers, billionaires, millionaires, surgeons, professors, scientists...they look just like everybody but they have a second life.
They are everywhere in finance, even your broker or a banker can be a junkie and they are all sick to me, I try to avoid them in my business because I don't trust any addicts. Addiction is a very dangerous thing and comes in 4 forms:
Drugs
Gambling
Women/Men
Alcoholism
If you don't know about it and how dangerous it can be then you are not ready for nothing, life is full of danger, market is run by criminals, all is manipulation of public opinion, all is lies.

Now back to (GWPRF.PK) and how they use cannabis to help people and save lives. Morphine is used for hundreds of years as a painkiller and GW Pharma now do the same with cannabinoid prescription drug Sativex that is used for treatment of cancer pain, here is their business profile:
GW Pharmaceuticals plc is a United Kingdom-based company. The Company is engaged in the business of research, development and commercialisation of a range of cannabinoid prescription medicines including Sativex Oromuscosal spray. Sativex treats a range of serious medical conditions. Sativex is marketed in Canada for the treatment of cancer pain and multiple sclerosis (MS) neuropathic pain. The Company’s subsidiaries include GW Pharma Limited, G-Pharm Limited, Guernsey Pharmaceuticals Limited and GWP Trustee Company Limited.

They are best positioned company to develop such "drugs from drugs" considering they are the only company in this field, big pharma will turn to them if any such big cap company will want to enter this field, they will do it together with GW or more likely buy GW for a big premium. Such growth doesn't come for free, for example GW Pharma sales grew from 3M GBP in 2005 and in 2009 reached 24M GBP or by 800% in 4 years.

WTFact
Market Cap 128M GBP
Shares Outstanding 130M (very conservative company that issued only 35M shares in the last decade)
EPS 0.012 GBP
P/E 73
EBIT 1M GBP (first time positive earnings in decade, before earnings were negative 95M GBP from year 2000)
Current Assets 29M GBP
Current Liabilities 23M GBP
LT Debt (no debt)
Major Shareholders insiders own 17%, Prudential Plc 13% (M&G Investment Management Ltd.), Great Point Partners Llc 6%, Dr. B. Whittle 8% the rest is owned by private investors such as me.

GW Pharma is a stock on drugs, instead of using drugs to get high I chose (GWP), ticker on AIM. For offshore or U.S. investors (GWPRF.PK) is the drug's code.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.